Quantcast

Latest immunotherapy Stories

2014-10-22 08:31:17

MISSISSAUGA, ON, Oct. 22, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced the results of a market study commissioned to investigate the U.S. opportunity for the Company's experimental immunotherapy product, WF10, as a treatment for patients with refractory allergic rhinitis. The study, performed by Psscion Lifesciences Consulting (Psscion), forecasts that WF10 could capture...

2014-10-15 12:32:29

LONDON, Oct. 15. 30, 2014 /PRNewswire/ -- REPORT HIGHLIGHTS The global cancer immunotherapies market reached $30.8 billion in 2012. This market is expected to grow to nearly $34.3 billion in 2013 and $67.9 billion in 2018 with a compound annual growth rate (CAGR) of 14.7% over the five-year period, 2013 to 2018. This report provides:An overview of the global market for cancer immunotherapiesAnalyses of global market trends, with data from 2012, estimates for 2013, and projections of...

2014-10-15 12:30:33

Oral Mucosal Immunotherapy Using A Toothpaste Delivery System Shows Promise For Treating Allergic Rhinitis MADISON, Wis., Oct. 15, 2014 /PRNewswire/ -- Shara Rudner, RPh., FIACP, FACA, Director, Clinical Trials Group for Restore Health, was part of a research collaboration that developed a new delivery system could help millions of people who suffer from seasonal allergies. The study results were featured in a national news story on Oct. 1, 2014....

2014-10-14 23:10:42

Today, the otolaryngology and allergy group announced it has reached agreement on a long term lease and construction of a brand new, state-of-the-art 10,146+ square foot facility in Port Jefferson, NY. Tarrytown, NY (PRWEB) October 14, 2014 ENT and Allergy Associates, LLP (ENTA) is the nation’s premier ear, nose, throat, allergy and audiology practice, with forty one offices providing unparalleled medical care to patients in New York and New Jersey in nineteen counties. And now it is...

2014-10-14 08:33:10

Robust Clinical Development Programs Across Sellas' Portfolio of Drugs and Biologics ZUG, Switzerland and NEW YORK, Oct. 14, 2014 /PRNewswire/ -- SELLAS Life Sciences Group (SELLAS), a Swiss-based development-stage biopharmaceutical company, today announced that it has signed a definitive master service agreement with Pharmaceutical Product Development (PPD), a leading global contract research organization (CRO), to advance and expand clinical and regulatory development across...

2014-10-14 04:22:05

TUBINGEN, Germany, October 14, 2014 /PRNewswire/ -- Regulatory authority approves clinical trial for Glioma Actively Personalized Vaccine Consortium (GAPVAC) First centers to enroll glioblastoma patients opened in Heidelberg and Tuebingen European Union supports the initiative with a EUR6 million grant immatics biotechnologies GmbH and BioNTech AG announce...

2014-10-09 16:24:03

Funds raised through the world's largest cancer cycling event series will power life-saving immunotherapy research, treatment and care in New York and around the world NEW YORK, Oct. 9, 2014 /PRNewswire/ -- New York's first annual Ride to Conquer Cancer launched to the public on Wednesday to raise vital funds for the Cancer Research Institute in Manhattan. Funds raised through the world's largest cancer cycling event series will power life-saving immunotherapy research in New York...

2014-10-08 12:28:18

SAN ANTONIO, Oct. 8, 2014 /PRNewswire/ -- United Allergy Services (UAS)(TM), the leading healthcare services company empowering providers and health systems to deliver safe and effective allergy testing and customized immunotherapy services, today announced that Brian Sassi has joined the UAS board of directors. http://photos.prnewswire.com/prnvar/20120626/MM31403LOGO "The future of UAS looks bright and I look forward to working with the board, and a talented executive team to bring...

2014-10-02 12:28:31

LONDON, Oct. 2, 2014 /PRNewswire/ -- This report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. Cancer immunotherapy was once just a dream in the minds of physicians, clinicians and patients, but only recently (2010s era) has it actually been within reasonable reach. Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies covers three principle therapies that have been in the...

2014-10-01 23:10:40

Australian researchers say they have cured mesothelioma in lab mice by giving them a combination of three immune system antibodies. Raleigh, NC (PRWEB) October 01, 2014 Scientists at the University of Western Australia say a combination of three drugs that target immune system proteins has the power to knock out mesothelioma in mice. Surviving Mesothelioma has just posted details of the new study on their website. Click here to read the story now. Researchers in the UWA School of...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.